Sealed Air Shareholders Approve CD&R Acquisition: Private Equity Take-Private Deal Advances

Sealed Air Corporation shareholders voted to approve the company’s acquisition by Clayton, Dubilier & Rice (CD&R), marking a key milestone in the private equity firm’s **take-private transaction** valued at approximately $5 billion including debt.[1] The approval, announced February 25, 2026, clears a major hurdle for the deal initially disclosed in late 2025, amid rising **private equity interest in industrial packaging**.

Most “AI for Diligence” tools are lying to you. The truth is, they are just ChatGPT wrappers. Experience what real AI for Diligence looks like, built like Claude Code, but for M&A/ PE Diligence:

💼 When Claude Code Marries Due Diligence!

Deal Terms and Timeline

CD&R agreed to acquire all outstanding shares of Sealed Air (NYSE: SEE) for $42 per share in cash, representing a 25% premium to the stock’s unaffected price.[1] The transaction, expected to close in the first half of 2026, will delist Sealed Air from the New York Stock Exchange, providing CD&R full control to execute operational improvements in food packaging and protective solutions.

• Equity value: ~$4 billion
• Total enterprise value: ~$5 billion (including net debt)
• Key backers: CD&R funds, with potential co-investors from prior portfolio maneuvers
• Regulatory status: Subject to customary antitrust clearances, including Hart-Scott-Rodino filing

Strategic Rationale and Industry Context

Sealed Air, a leader in sustainable packaging for food and e-commerce, generated $5.1 billion in 2025 revenue, with strong exposure to protein processing and automated systems like the 4,000th Rotary Vacuum Packaging installation milestone.[1] CD&R targets **private equity value creation in industrials** through cost discipline, supply chain optimization, and bolt-on acquisitions—strategies honed in prior deals like the $13 billion AptarGroup investment.

Bain & Company notes that **private equity take-private strategies in packaging** surged 30% in 2025, driven by undervalued public multiples amid inflation pressures and margin contraction.[1] McKinsey highlights synergies in Sealed Air’s Cryovac and Bubble Wrap brands, projecting 10-15% EBITDA uplift via digital automation and sustainability upgrades, aligning with EU packaging regulations.

Shareholder and Analyst Views

Prior to approval, analysts maintained a “Moderate Buy” consensus on Sealed Air, with upgrades from Royal Bank of Canada and JPMorgan citing resilient demand in food security packaging.[1] Institutional moves included new stakes by Wealth Enhancement Advisory and Woodline Partners, signaling confidence in the deal premium despite share sales by AQR and Rhumbline.

Kirkland & Ellis, advising CD&R, structured the **leveraged buyout financing** with commitments from Goldman Sachs and KKR credit arms, reflecting tight high-yield markets in early 2026. Comparable deals include CD&R’s 2024 DuPont nutrition spin-off carveout, which delivered 3x returns via operational carve-outs.

Implications for M&A and PE Exits

This approval underscores **cross-border M&A trends 2025-2026** in essentials sectors, where PE firms like CD&R pursue 4-6 year holds with **private equity exit strategies in industrials** targeting IPOs or strategic sales amid normalizing rates. BCG forecasts $200 billion in packaging PE activity through 2028, fueled by e-commerce growth and sustainability mandates.

Sealed Air executives anticipate minimal disruptions, with no immediate layoffs signaled, focusing instead on R&D in recyclable films. Investors eye CD&R’s track record: 85% IRR average in food/agri platforms.